These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 491306)

  • 21. [Evaluation of plasma renin activity in patients under chronic dialysis treatment (author's transl)].
    Kaneda H; Murata T; Matsumoto J; Haruyama T
    Nihon Naika Gakkai Zasshi; 1979 Mar; 68(3):276-84. PubMed ID: 399487
    [No Abstract]   [Full Text] [Related]  

  • 22. [The activities of the renin-angiotensin-aldosterone and sympathetic-adrenal systems during hemodialysis].
    Akopian AS; Koriakin MV; Golubov AA; Shevchenko AV
    Urol Nefrol (Mosk); 1991; (4):45-50. PubMed ID: 1659015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
    Lifshits NL; Kutyrina IM
    Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endocrine functions following epidural morphine in man. II. Effects on renal function and plasma ADH and aldosterone levels and plasma renin activity (author's transl)].
    Yao M; Tanioka F; Ishihara H; Kudo T; Matsuki A; Oyama T
    Masui; 1981 Dec; 30(12):1353-63. PubMed ID: 7050457
    [No Abstract]   [Full Text] [Related]  

  • 25. Vasoactive hormones in children with chronic renal failure.
    Rauh W; Hund E; Sohl G; Rascher W; Mehls O; Schärer K
    Kidney Int Suppl; 1983 Nov; 15():S27-33. PubMed ID: 6368949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma aldosterone during haemodialysis in patients with terminal renal failure].
    Schnurr E; Küppers H; Wiesen K; Grabensee B
    Dtsch Med Wochenschr; 1976 Jul; 101(30):1120, 1125-8. PubMed ID: 1278056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renin-angiotensin-aldosterone system in patients on maintenance hemodialysis.
    Ivić M; Strahinjić S; Stefanović V
    Acta Med Iugosl; 1987; 41(3):205-13. PubMed ID: 3661237
    [No Abstract]   [Full Text] [Related]  

  • 28. The renin-angiotensin-aldosterone system in patients with chronic primary glomerular diseases.
    Tanaka T; Hashimoto H; Ohba H; Abe M; Yagi S
    Nihon Jinzo Gakkai Shi; 1986 Sep; 28(9):1261-6. PubMed ID: 3546877
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood volume, plasma renin activity and plasma aldosterone concentration in patients with essential hypertension who were treated for more than ten years (author's transl)].
    Nakamura Y
    Nihon Naika Gakkai Zasshi; 1980 Jun; 69(6):714-22. PubMed ID: 6997417
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma aldosterone during haemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbuster H; Strebel U; Beckerhoff R; Siegenthaler W
    Proc Eur Dial Transplant Assoc; 1973; 10(0):332-41. PubMed ID: 4370265
    [No Abstract]   [Full Text] [Related]  

  • 31. [Blood pressure and renin in long-term hemodialysis patients].
    Shin J; Sakai R; Nishioka M; Okudaira H; Arakawa T; Fujita Y; Komaba K; Nagai H
    Nihon Jinzo Gakkai Shi; 1996 Jan; 38(1):13-21. PubMed ID: 8855132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma angiotensin II, renin, renin-substrate and aldosterone concentrations in acute renal failure in man.
    Paton AM; Lever AF; Oliver NW; Medina A; Briggs JD; Morton JJ; Brown JJ; Robertson JI; Fraser R; Tree M; Gavras H
    Clin Nephrol; 1975 Jan; 3(1):18-23. PubMed ID: 1126059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A; Shaldon S; Barjon P; Mion C
    Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Falsely elevated plasma aldosterone concentration by direct radioimmunoassay in chronic renal failure.
    Koshida H; Miyamori I; Miyazaki R; Tofuku Y; Takeda R
    J Lab Clin Med; 1989 Sep; 114(3):294-300. PubMed ID: 2769019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activity of plasma renin in patients with terminal renal insufficiency kept on chronic hemodialysis].
    Lifshits NL; Ermolenko VM; Sumarokov AV; Tatsievskiĭ VA; Kondakhchan MA
    Ter Arkh; 1975; 47(4):81-8. PubMed ID: 1145487
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes in serum osmolality during hemodialysis of patients with chronic renal insufficiency (author's transl)].
    Loutocký A; Lachmanová J; Tomásek R; Horký K
    Cas Lek Cesk; 1977 Feb; 116(6):177-81. PubMed ID: 851974
    [No Abstract]   [Full Text] [Related]  

  • 38. Control of plasma aldosterone during chronic hemodialysis.
    Studer A; Záruba K; Grimm J; Kuhlmann U; Siegenthaler W; Vetter W
    Clin Nephrol; 1980 Apr; 13(4):172-6. PubMed ID: 6991183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
    Papadimitriou M; Vyzantiadis A; Milionis A; Memmos D; Metaxas P
    Life Support Syst; 1983; 1(3):197-205. PubMed ID: 6433115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The renin-angiotensin-aldosterone system in terminal renal failure.
    Weidmann P; Maxwell MH
    Kidney Int Suppl; 1975 Sep; ():S219-34. PubMed ID: 1104972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.